Art of Youniverse Announces Strategic Partnership and Minority Investment from Saanroo, the Ingredient Innovator Formerly Known as Gencor

Art of Youniverse, a Europe-based preventive care technology company offering pharmaceutical-grade personalized supplementation, today announced that Saanroo has taken a minority equity stake in the company. The investment follows direct conversations between Saanroo’s leadership and Art of Youniverse co-founders Anna Sekalska and Pablo Smolders.

The partnership goes beyond capital. Art of Youniverse and Saanroo will collaborate on joint formulation development, combining Saanroo’s portfolio of clinically studied, proprietary ingredients with Art of Youniverse’s biomarker-based personalization technology.

About Saanroo

Saanroo, formerly known as Gencor, is a global ingredient company with a portfolio of high-end, trademarked botanical ingredients backed by clinical trials. Their branded compounds, including Levagen®, affron®, HydroCurc®, and Testofen®, among others, are used by premium supplement manufacturers worldwide. Beyond ingredient supply, Saanroo operates its own product line and has developed proprietary delivery technologies designed to improve the bioavailability of its compounds.

Saanroo’s decision to invest in Art of Youniverse reflects a shared conviction that genuine personalization, not mass-market formulation, is the future of supplementation.

What the Partnership Enables

The collaboration between Art of Youniverse and Saanroo creates a foundation for a new standard in personalized supplementation:

• Minority shareholding: Saanroo becomes a formal stakeholder in Art of Youniverse’s growth.
• Joint formulation development: Both organizations will develop formulations that combine Saanroo’s clinically validated ingredients with Art of Youniverse’s individualized approach.
• Strategic alignment: The partnership strengthens Art of Youniverse’s scientific and ingredient infrastructure for the long term.

“We are truly honoured to welcome Saanroo as an investor in Art of Youniverse. Saanroo doesn’t just bring capital — they bring knowledge, integrity, and a shared belief that what we put into our bodies profoundly shapes how we experience life. Together, we are building something that genuinely matters for the generations ahead.”

— Anna Sekalska, Co-CEO, Art of Youniverse

About Art of Youniverse

Art of Youniverse is a Europe-based preventive care technology company offering personalized supplementation based on individual biomarker analysis. Formulas are produced using ACG’s multi-patented Personalised Capsule Machine, technology originally developed for pharmaceutical-grade production. The personalization algorithm was developed in cooperation with the Centre for Nutraceuticals at the University of Westminster. Art of Youniverse delivers its personalized plans in two capsules per day, using precision beadlet technology for time-release delivery.